PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2 [electronic resource]
Producer: 20170801Description: 637-648 p. digitalISSN:- 1538-8514
- Aminopyridines -- administration & dosage
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Drug Synergism
- Endometrial Neoplasms -- drug therapy
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Indazoles -- administration & dosage
- Mice
- Morpholines -- administration & dosage
- Mutation
- Phenylurea Compounds -- administration & dosage
- Phosphoinositide-3 Kinase Inhibitors
- Pyrimidines -- administration & dosage
- Receptor, Fibroblast Growth Factor, Type 2 -- antagonists & inhibitors
- Sulfonamides -- administration & dosage
- Thiazoles -- administration & dosage
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.